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Abstract 16 
Sepsis caused by LPS is characterized by an intense systemic inflammatory response affecting 17 
the lungs, causing acute lung injury (ALI). Dysfunction of mitochondria and the role of 18 
reactive oxygen (ROS) and nitrogen species produced by mitochondria have already been 19 
proposed in the pathogenesis of sepsis; however, the exact molecular mechanism is poorly 20 
understood. Oxidative stress induces cyclophilin D (CypD)-dependent mitochondrial 21 
permeability transition (mPT), leading to organ failure in sepsis. In previous studies mPT was 22 
inhibited by cyclosporine A which, beside CypD, inhibits cyclophilin A, B, C and calcineurin, 23 
regulating cell death and inflammatory pathways. The immunomodulatory side effects of 24 
cyclosporine A make it unfavorable in inflammatory model systems. To avoid these 25 
uncertainties in the molecular mechanism, we studied endotoxemia-induced ALI in CypD
-/-
 26 
mice providing unambiguous data for the pathological role of CypD-dependent mPT in ALI. 27 
Our key finding is that the loss of this essential protein improves survival rate and it can 28 
intensely ameliorate endotoxin-induced lung injury through attenuated proinflammatory 29 
cytokine release, down-regulation of redox sensitive cellular pathways such as MAPKs, Akt, 30 
and NF-κB and reducing the production of ROS. Functional inhibition of NF-κB was 31 
confirmed by decreased expression of NF-κB-mediated proinflammatory genes. We 32 
demonstrated that impaired mPT due to the lack of CypD reduces the severity of 33 
endotoxemia-induced lung injury suggesting that CypD specific inhibitors might have a great 34 
therapeutic potential in sepsis-induced organ failure. Our data highlight a previously unknown 35 
regulatory function of mitochondria during inflammatory response. 36 
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1. Introduction 41 
 42 
Sepsis is a severe systemic inflammatory process caused by bacterial agents, such as 43 
lipopolysaccharide (LPS). LPS plays a crucial role in the induction of inflammatory responses 44 
and acute lung injury (ALI), leading to acute respiratory distress syndrome (ARDS) [1, 2]. 45 
The binding of LPS to toll-like receptor (TLR) 4 initiates signaling pathways, culminating in 46 
the activation of mitogen-activated protein kinases (MAPK) and NF-κB [3, 4]. As a 47 
consequence of NF-κB activation, the expression of cytokines and chemokines is up-48 
regulated, causing neutrophil infiltration into the lung [5, 6, 7]. Leukocytes produce reactive 49 
oxygen species (ROS) and nitrogen monoxide (NO), in order to eliminate pathogens. 50 
However, the excessive production of these reactive agents can damage cellular components 51 
and lead to epithelial and endothelial cell death and tissue damage. LPS-induced ROS can 52 
further enhance the activity of redox-sensitive inflammatory transcription factors and 53 
signaling kinases such as MAPKs and Akt [8-11].  54 
Cytosolic Ca
2+
 overload or ROS can trigger the opening of mitochondrial permeability 55 
transition (mPT) pore leading to the collapse of ATP production, release of proapoptotic 56 
molecules and initiating further ROS production. Cyclophilin D (CypD), a matrix peptidyl-57 
prolyl cis-trans-isomerase, encoded by the nuclear Ppif gene, is a modulator of mPT although 58 
the exact molecular composition of the pore is still under debate [12, 13]. Studies with 59 
mitochondria lacking CypD demonstrated very low Ca
2+
-sensitivity and delayed mPT pore 60 
opening, clearly favoring an indispensable modulatory role of CypD [14, 15, 13]. The 61 
generally used inhibitor of mPT is cyclosporine A (CsA) [16] which inhibits, not only CypD, 62 
but also cyclophilin A, B, C and calcineurin, therefore has a wide range of signaling effects – 63 
including inflammatory signaling - unrelated to CypD [17-20]. Thus, immunomodulatory 64 
effects of CsA make it unfavorable for investigating the role of mPT under inflammatory 65 
conditions. The role of mPT has been implicated in many pathological conditions 66 
accompanied by oxidative damage; however, there are only a few studies regarding the role of 67 
mPT in inflammatory processes, and no experiment has been conducted to date to evaluate its 68 
participation in ALI. Here, we give the first specific evidence for the role of CypD-dependent 69 
mPT in ALI using CypD knock-out mice. 70 
 71 
2. Materials and methods 72 
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2.1. Ethics Statement 73 
Animal experiments were performed according to Hungarian Governmental Regulation 74 
40/2013. (II. 14.) in accordance to the Directive 2010/63/EU of the European Parliament and 75 
of the Council on the protection of animals used for scientific purposes. The license was 76 
approved by the County Governmental Office (No. BA02/2000-20/2011) lasting for five 77 
years (2013-2017). 78 
 79 
2.2. Animals 80 
Male C57BL/6 mice were from Charles River Hungary Breeding and genetically engineered 81 
homozygous male Ppif-/- cyclophilin D knock-out mice with C57BL/6 background were 82 
supplied by Prof. László Tretter (Semmelweis University, Budapest, Hungary). The mice 83 
were kept under standard conditions.  84 
 85 
2.3. Materials 86 
LPS from Escherichia coli 0127:B8 and all materials that are not specified elsewhere were 87 
purchased from Sigma-Aldrich (St. Louis, MO). Anti-phospho-p44/42, anti-p44/42, anti-88 
phospho-Akt, anti-Akt, anti-phospho-p38, anti-p38, anti-phospho-JNK, anti-JNK, anti-89 
phospho-NF-κB p65, anti-NF-κB p65, anti-phospho-IκBα and anti-IκBα primary antibodies 90 
for immunoblotting were from Cell Signaling Technology (Danvers, MA), anti-MKP-1, anti-91 
4-hydroxy-2-noneal Michael adducts, anti-nitrotyrosine and anti-GAPDH antibodies were 92 
from Millipore (Billerica, MA).  93 
 94 
2.4. ALI model and survival study 95 
To induce murine endotoxemia, intraperitoneal LPS (40 mg/kg, dissolved in PBS) was given, 96 
control groups received PBS (10 μl/g). Primarily survival study was performed with age–97 
matched wild type (n=8) and CypD knock-out mice. Mice were monitored for clinical signs 98 
of endotoxemia and lethality every hour for 96 h, after that they were monitored 3 times a day 99 
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till the end of the first week. No late deaths were observed in any of the experimental groups. 100 
Alternatively, 24 hours after treatment the mice were anesthetized with isoflurane 101 
(Isopharma). Lungs were removed, and processed as follows: the right upper lobe was fixed 102 
in 10% paraformaldehyde, except for a piece which was put into primary fixative (2% 103 
paraformaldehyde / 2% glutaraldehyde) for electronmicroscopy; the right lower lobes were 104 
snap frozen in liquid N2; the left upper lobe was put into RNAlater RNA stabilization reagent 105 
(Qiagen, Hilden, Germany); the left lower lobe lung homogenate was prepared as described 106 
later. 107 
 108 
2.5. Western blot analysis 109 
10 mg of frozen tissue was homogenized (50 mM TRIS, 50 mM EDTA, 50 mM sodium 110 
metavanadate, 0.5% protease inhibitor cocktail, 0.5% phosphatase inhibitor cocktail, pH=7.4) 111 
and the protein concentration was determined with a DC™ Protein Assay kit (Bio-Rad, 112 
Hercules, CA). Western blotting was performed as described previously [9]. Peroxidase 113 
labeling was visualized with the Pierce ECL Western Blotting Substrate (Thermo Scientific, 114 
Waltham, MA) detection system. Quantification of band intensities of the blots was 115 
performed by ImageJ software.  116 
 117 
2.6. Cytokine determination by ELISA from lung homogenate 118 
After removal of the left lower lobe, the tissue was rinsed in ice-cold PBS and homogenized. 119 
Protein concentration was determined with DC™ Protein Assay kit (Bio-Rad). TNFα, IL-1β 120 
and IL-10 concentrations were measured with ELISA Ready-SET-Go! (eBioscience, San 121 
Diego, CA): 200 μg protein/well was used, the cytokine-amount was expressed in optical 122 
density at 450 nm. 123 
 124 
2.7. mRNA isolation from lung tissue and quantitative RT-PCR 125 
RNA was isolated from tissue samples kept in RNALater (Qiagen) solution using TRIzol 126 
reagent (Invitrogen, Grand Island, NY). Total RNA concentration was determined using 127 
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spectrophotometric method (IMPLEN NanoPhotometerTM, München, Germany) and reverse-128 
transcribed into cDNA with MMLV RT / RevertAid™ First Strand cDNA Synthesis Kit 129 
(Fermentas, Burlington, Canada). RT-PCR was performed with 1μl of cDNA in MiniOpticon 130 
Real-Time PCR System (Bio-Rad) using SYBR Green Supermix kit (Bio-Rad). Specific 131 
primers against CD14, IL-1α, Cxcl2, IFN-γ, iNOS, TNFα and actin were used. The relative 132 
gene expression was calculated with ΔΔCt method using BIO-RAD CFX Manager software. 133 
 134 
2.8. Pulmonary histopathology 135 
The paraformaldehyde fixed superior lobe of the right lung was embedded in paraffin and cut 136 
into 5 μm sections. Hematoxylin-eosin staining was performed using standard protocol. Slides 137 
were scored in a double blinded manner by an independent expert using the scoring system 138 
described previously [21]. Five slides in each group were assessed under high power field and 139 
evaluated for intra-alveolar and interstitial neutrophil accumulation, presence of proteinaceous 140 
debris and hyaline membrane, and also alveolar wall thickening. 141 
 142 
2.9. Immunohistochemistry 143 
The lung tissue sections were probed with antibodies against 4-hydroxy-2-noneal Michael 144 
adducts and nitrotyrosine. Formalin-fixed, paraffin-embedded 5µm tissue sections were 145 
deparaffinized and rehydrated followed by heat-induced epitope retrieval using 97°C heat 146 
exposure for 20 min. Sections were incubated in primary antibody over-night. Blocking and 147 
staining procedures were performed with Dako EnVision™ FLEX detection system with 148 
Dako Autostainer Plus instruments (Glostrup, Denmark). All sections were counterstained 149 
with hematoxylin. 150 
 151 
2.10. Electron microscopy  152 
Tissue samples were rinsed in 0.1 M phosphate buffer then fixed in 2 % glutaraldehyde / 2 % 153 
paraformaldehyde for 3 hours. After a post-fixation step (osmium tetraoxide 1 % in 0.1 M 154 
phosphate buffer) samples were dehydrated and embedded into Durcupan epoxy resin. Serial 155 
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ultrathin sections were cut and collected on cupper grids, then passed onto drops of uranyl 156 
acetate, later on lead citrate. Following the routine counterstaining samples were rinsed in 157 
distilled water and dried. Samples were observed and documented with JEOL 1200 (Tokyo, 158 
Japan) transmission electron microscope. 159 
2.11. Statistical analysis  160 
Comparisons between experimental groups were made by one-way ANOVA and post-hoc 161 
test. Data represent mean ± SEM. A value of p < 0.05 was considered statistically significant.  162 
 163 
3. Results 164 
3.1. Mice lacking CypD survive lethal endotoxemia 165 
CypD knock-out animals exhibited improved survival rate after intraperitoneal high dose LPS 166 
treatment compared to wild type mice. Out of the 8 CypD
-/-
mice two (25%) died within the 167 
first 30 hours but after that no deaths occurred. However all of the 8 wild type mice died 168 
within 60 hours (Figure 1). These results show that the loss of CypD massively reduces 169 
mortality. 170 
 171 
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Figure 1. Mice lacking CypD survive lethal endotoxemia. Survival study was carried out 172 
with age-matched wild-type (n=8) and CypD knock-out mice (n = 8). Survival was monitored 173 
for 7 days, after 40 mg/kg intraperitoneal LPS administration. 174 
 175 
3.2. CypD knock-out mice are protected against LPS-induced histopathological changes 176 
Histological examination revealed severe lung injury in LPS-treated wild type animals. On 177 
hematoxylin-eosin stained sections, alveolar wall thickening, blood vessel congestion and 178 
perivascular exudation were seen, which are suggestive of impaired tissue architecture and 179 
function, while robust interstitial neutrophil infiltration indicated ongoing immune response 180 
(Figure 2C). Interstitial accumulation of neutrophils was markedly decreased in LPS-treated 181 
CypD
-/-
mice (Figure 2E, 2F). Other pathological changes like alveolar widening and 182 
perivascular edema were also significantly milder in CypD
-/- 
lungs and no thrombotic event 183 
could be observed despite moderate congestion (Figure 2D). Lungs of control animals in both 184 
groups had normal tissue architecture with thin alveolar walls, occasional intra-alveolar 185 
macrophages and few neutrophils (Figure 2A, 2B). For making histological examination 186 
quantitative a scoring was performed as described earlier (Figure 2G). Scores were 187 
significantly higher in the LPS-treated wild type mice compared to CypD knock-outs mainly 188 
resulting from marked differences in interstitial neutrophil accumulation and alveolar 189 
thickening.  190 
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 191 
 192 
 193 
Figure 2. Deletion of CypD prevents lung vascular permeability, edema, and 194 
inflammation induced by LPS. Representative pathological and histological analysis of 195 
lungs from untreated (A) and LPS-treated (C) wild type mice, as well as from untreated (B) 196 
and LPS-treated (D) CypD knock-out mice. Enlarged light microscopic images highlight 197 
differences of vascular events in LPS-treated wild type (E) and knock-out mice (F). Arrows 198 
pointing on marginating and transmigrating leukocytes, arrowheads indicate severe 199 
endothelial leakage with consequent perivascular edema. Original magnification was 10X 200 
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(A,B,C,D) and 40X (E,F). Scale bars represent 100 µm. Histological scoring was also 201 
performed in double blinded manner according to the recommendations of the American 202 
Thoracic Society (G). Results are presented as mean ± SEM, n = 5. Significant difference 203 
between control and LPS-treated wild type animals is indicated by ± ( p < 0.001), significant 204 
difference between LPS-treated wild type and CypD knock-out animals is indicated by * (P < 205 
0.05). 206 
 207 
3.3. Lack of CypD prevents the fine structural anatomy of lung tissue damaged by LPS 208 
LPS treatment induced serious lesions in the lung tissue of wild type mice. Endothelial cells 209 
were swollen loaded with cytoplasmic vacuoles and the number of pinocytotic vesicles was 210 
increased (Figure 3C, 3I). Inter-endothelial connections of endothelial cells were damaged or 211 
dilated (Figure 3M). An impaired, leaky endothelial layer of blood vessels allowed 212 
extravasation of intravascular fluid resulting in tissue edema. Another sign of impaired blood 213 
vessel functioning was a detached basal membrane with an unsettled fibroelastic layer in the 214 
alveolar septa (Figure 3D). These denuded surfaces are potential targets of fibrin attachment 215 
and hyaline membrane formation. The proinflammatory activity of fibrin fragments and 216 
massive liberation of immune cell molecules may explain the appearance of a considerable 217 
amount of cell debris. Obvious thickening of the alveolar septa by accumulated connective 218 
tissue indicates strong fibrosis (Figure 3D). Tissue organization of CypD
-/- 
mice with or 219 
without LPS treatment was almost identical to that of wild type untreated animals (Figure 3A, 220 
3B, 3G-L). The level of septal thickening was not comparable to that in wild type LPS-treated 221 
animals (Figure 3D, 3E). This observation indicates the quicker resolution of acute lung tissue 222 
lesions or much milder tissue injury. 223 
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 224 
Figure 3. Lack of CypD prevents the fine structural anatomy of lung tissue damaged by 225 
LPS. (A) In untreated wild type mice blood vessel endothelial cells (ec) attach intact 226 
basement membrane (bm). Dense layer of fibro elastic membrane supports interseptal wall 227 
(arrow). er: erythrocyte, cl: collagen fibers. (B) In CypD knock-out mice intact basement 228 
membrane (bm) and endothelial cell (ec) are visible. Prominent fibro elastic layer (arrow) 229 
lying beneath basement membrane. (C, D) LPS-treated wild type mice show seriously 230 
12 
 
degenerating portion of an endothelial cell (ec) with large vacuoles appearing in cytoplasm 231 
(arrows, C) and thinner basement membrane (bm). Number and size of pinocytotic vesicles 232 
(stars) are increased, cytoplasm is swollen. Widened inter endothelial junction (circle) is also 233 
shown. Portions of endothelial cells are focally detached from basal membrane (arrows, D). 234 
Denuded patches serve potential surfaces to fine fibrin branches (fb) to attach. Blood vessel 235 
lumen is congested with platelets (pl). (E, F) In CypD knock-out LPS-treated mice the 236 
structure of blood vessel walls is almost identical with that of control animals. Intact 237 
endothelial cell (ec) basement membrane (bm) and fibro elastic membrane (arrow, E) are 238 
shown. Diffuse appearance of collagen fibers (cl) could also be observed. In some cases intact 239 
endothelial cell (ec) portions were seen focally detached (arrow, F) from basement membrane 240 
(bm). Cytoplasmic swelling could not be seen. (G, H) Fine structure of endothelial cells show 241 
no morphological changes between CypD
+-+
 vs CypD
-/-
. (I, J) Serious endothelial cytoplasmic 242 
degeneration is visible (arrow, I) in LPS-treated wild type compared to knock-out mice. (K, 243 
L) Dense membrane sections of inter endothelial junctions (arrows) in blood vessel walls are 244 
intact both in wild type and CypD knock-out control animals. (M, N) Arrows show widened 245 
and intact thigh junctions in blood vessel wall of LPS-treated wild type and CypD knock-out 246 
animals, respectively. Scale bars: 500 nm. 247 
 248 
3.4. Loss of CypD protects lung epithelial cells against oxidative damage  249 
Lung tissue sections were examined with immunohistochemistry using antibodies against 250 
nitrotyrosine, and 4-hydroxy-2-noneal Michael adducts. LPS treatment markedly enhanced 251 
immunohistochemical staining in endothelial and lung epithelial cells of wild type animals. 252 
Endothelial and epithelial cells of CypD
-/-
 mice showed less intense staining (Figure 4A). The 253 
extensive lipid-peroxidation damage after LPS treatment in wild type animals was also visible 254 
regarding bronchial mucinosus cells. In contrast, endotoxemic CypD
-/- 
mice exhibited a 255 
markedly reduced staining of endothelial tissue, while the intensity of epithelial positivity was 256 
almost the same as in wild type and knock-out animals without LPS treatment (Figure 4B). 257 
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Figure 4. Loss of CypD protects the lung epithelial cells against oxidative damage. 259 
Immunohistochemical staining of mouse lungs for nitrotyrosine (A) and for 4-hydroxy-2-260 
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noneal Michael adducts (B) in lung tissue counterstained with hematoxylin. Endothelia of 261 
lung vessels in LPS-treated wild type mice were intensively stained compared to CypD 262 
knock-out mice. Epithelial cells showed prominent positivity in wild type, but not in knock-263 
out LPS-treated animals. Star indicates airway lumen with strong positivity of bronchial cells 264 
and secretory product. Scale bar represents 100 µm. 265 
 266 
3.5. Absence of CypD impairs proinflammatory, but does not affect anti-inflammatory 267 
cytokine production 268 
During ALI, early phase cytokines promote the production of chemokines by resident cells to 269 
enhance neutrophil sequestration into the lung. Clinical studies have proven the importance of 270 
these factors, since the outcome of patients with ARDS significantly correlates with the 271 
concentration of these cytokines in bronchoalveolar lavage fluid [7, 21, 22]. In our 272 
experiments, LPS treatment resulted in elevated TNFα and IL-1β levels, measured in lung 273 
homogenates, while the amount of these cytokines was markedly decreased in LPS-treated 274 
CypD
-/-
 mice (Figure 5A, 5B). IL-10, responsible for limiting inflammatory processes, 275 
ameliorates endotoxemia-induced ALI and high levels in the lungs of patients suffering from 276 
ARDS correlated with better outcome [23, 24]. In our study, there was no difference in the 277 
amount of anti-inflammatory IL-10 in total lung homogenates between wild type and knock-278 
out animals 24h after LPS administration (Figure 5C), as both increased significantly. 279 
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 280 
Figure 5. Effect of LPS on cytokine production of wild type and CypD
-/- 
mice. 281 
Determination of proinflammatory cytokines TNFα (A) and IL-1β (B), and anti-inflammatory 282 
cytokine IL-10 (C) 24 h after LPS-treatment from total lung homogenates by ELISA. Bars 283 
represent mean ± SEM of optical densities, n = 4. Significant difference between control and 284 
LPS-treated wild type animals is indicated by ± (p < 0.05), significant difference between 285 
LPS-treated wild type and CypD knock-out animals is indicated by * (P < 0.05). 286 
 287 
3.6. Deficiency of CypD affects the activation of MAPKs through MKP-1 and Akt in 288 
mouse lungs after LPS treatment 289 
Phosphorylation and activation of MAPKs was shown to play an important role in the 290 
development of ALI following LPS exposure [25, 26]. In our experiments, phosphorylation 291 
levels of extracellular signal-regulated kinase (ERK), p38, and c-Jun N-terminal kinase (JNK) 292 
were significantly elevated 24 hours after LPS treatment in wild type animals, while the 293 
activation of ERK and p38 was lower in the lungs of LPS-treated CypD
-/-
 mice (Figure 6A, 294 
B). No difference could be observed in JNK phosphorylation between knock-out and wild 295 
type animals after LPS challenge (Figure 6C).  296 
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MAP kinases are under the direct negative regulation through dephosphatase activity of 297 
MAPK-phosphatase-1 (MKP1). The level of MKP1 was up-regulated in CypD
-/-
 mice 298 
compared to wild type animals after LPS treatment (Figure 6D).  299 
Beside MAP kinases Akt contributes to the TLR4 signaling cascade leading to NF-κB 300 
activation and promoting inflammatory processes in the lung. In our experiment, LPS 301 
treatment significantly enhanced the phosphorylation of Akt in the lungs of wild type animals, 302 
while this effect was strongly reduced in CypD
-/-
 animals, resulting in a phosphorylation level 303 
that was comparable to that seen in control animals (Figure 6E).  304 
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Figure 6. Deficiency of CypD affects MAPKs, MKP-1 and Akt in mouse lungs after LPS 306 
treatment. Activation of ERK (A), p38 (B), SAPK/JNK (C), MKP-1 (D) and Akt (E) in lung 307 
total homogenates was determined 24 h after LPS treatment by immunoblotting utilizing 308 
phosphorylation specific and total primary antibodies. Total proteins (non-phosphorylated) 309 
and GAPDH were used as loading controls. A representative blot as well as a bar diagram of 310 
the quantified blots are presented. Bars represent mean ± SEM of pixel densities, n = 4. 311 
Significant difference between control and LPS-treated wild type animals is indicated by ± ( p 312 
< 0.05), significant difference between LPS-treated wild type and CypD knock-out animals is 313 
indicated by * (p < 0.05). 314 
 315 
3.7. CypD knock-out mice do not exhibit prominent NF-κB activation after LPS 316 
treatment 317 
We determined the phosphorylation level of the p65 subunit of NF-κB and inhibitory-κB 318 
(IκB). LPS caused a significant activation of NF-κB in wild type mice compared to CypD-/- 319 
animals (Figure 7A). Similarly, robust IκB phosphorylation was found in wild type animals 320 
after LPS treatment; however, CypD
-/-
 mice showed decreased phosphorylation, which seems 321 
to confirm our data regarding NF-κB activation (Figure 7B). 322 
 323 
Figure 7. CypD is required for LPS-induced NF-κB activation. Phosphorylation of NF-κB 324 
(A) and IκB (B) in lung total homogenates was determined 24 h after LPS treatment by 325 
immunoblotting, utilizing phosphorylation specific primary antibodies. Total proteins (non-326 
phosphorylated) and GAPDH were used as loading controls. A representative blot as well as a 327 
bar diagram of the quantified blots are presented. Bars represent mean ± SEM of pixel 328 
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densities, n = 4. Significant difference between control and LPS-treated wild type animals is 329 
indicated by ± ( p < 0.001), significant difference between LPS-treated wild type and CypD 330 
knock-out animals is indicated by * (P < 0.05). 331 
 332 
3.8. Marked differences between wild type and CypD knock-out animals regarding NF-333 
κB-mediated gene expression 334 
To gain further insight into the functional inhibition of NF-κB, we determined the gene 335 
expression of NF-κB-regulated inflammatory mediators that are crucial in the 336 
pathophysiology of LPS-induced ALI using qRT-PCR. Expression of CD14, CXCl2, IFNγ, 337 
TNFα, IL-1 and inducible NO synthase (iNOS) was elevated in LPS-treated wild type 338 
animals; this LPS-induced overexpression was strongly reduced in every case in the knock-339 
out mice. Our data show that NF-κB regulation in CypD-/- animals is not limited to the level 340 
of phosphorylation of key signaling enzymes, but it affects the transcription of the related 341 
genes as well (Figure 8). 342 
20 
 
 343 
Figure 8. CypD regulates LPS-induced NF-κB-mediated gene expression. The expression 344 
of NF-κB-mediated inflammatory genes, CD14 (A), IFN-γ (B), TNFα (C), IL-1α (D), Cxcl2 345 
(E) and iNOS (F) was determined 24h after LPS treatment in lung tissue by RT-PCR. Actin 346 
was used as a housekeeping gene to generate the ΔCt values. Data were normalized to ΔCt 347 
values of untreated controls. Results are presented as mean ± SEM, n = 4. Significant 348 
difference between control and LPS-treated wild type animals is indicated by ± ( p < 0.001), 349 
significant difference between LPS-treated wild type and CypD knock-out animals is 350 
indicated by * (P < 0.05). 351 
 352 
4. Discussion 353 
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 354 
In the present study, we demonstrated that a deficiency of CypD ameliorates pathological 355 
consequences of endotoxemia-induced ALI, both at the tissue and molecular levels, and 356 
massively reduces mortality rate. Cyclophilins are ubiquitous proteins differing in their 357 
subcellular localization and binding affinity to CsA. CsA inhibits calcineurin thereby 358 
suppresses MKP-1 expression resulting in increased MAPK activation [27]. Therefore, 359 
considering the importance of MAPKs in NF-κB activation, CsA is obviously unsuitable for 360 
studying the effect of mPT impairment on LPS-induced inflammatory response. To resolve 361 
this problem and to focus on the role of CypD and mPT on LPS-induced inflammation, we 362 
used a CypD
-/-
 model.  363 
LPS is known to cause excessive inflammatory response with oxidant-antioxidant imbalance 364 
in many organs, severely affecting the lungs. Lung epithelial cells and macrophages, as well 365 
as sequestered neutrophils produce excessive amounts of ROS, amplifying oxidant events. 366 
Mitochondrial ROS production-induced cellular damage has been implicated in the 367 
pathophysiology of LPS-induced inflammation and ALI [28] characterized by endothelial 368 
barrier dysfunction, interstitial edema and thickening, epithelial damage, and the 369 
accumulation of neutrophils. Our histological results showed the same characteristics in the 370 
lungs of LPS-challenged wild type mice, but animals lacking CypD showed only mild tissue 371 
injury. Histological scores supported these findings. The deleterious effect of ROS on 372 
endothelial and epithelial morphology and barrier function has been demonstrated at the 373 
subcellular fine structural level using electron microscopy; however, a definitive protective 374 
effect was found in CypD-deficient mice. Our results suggest that the loss of CypD greatly 375 
diminishes ROS and RNS production after LPS treatment with the consequent attenuation of 376 
microscopic and subcellular pathological changes and oxidative tissue damage in the lungs of 377 
mice. 378 
ROS contribute to the inflammatory phenotype, with the increased production of 379 
proinflammatory cytokines in lung cells. Elevated concentrations of proinflammatory 380 
chemokines and cytokines, including IL-8, IL-1β, and TNFα, in the lungs are critical 381 
regulators of the outcome of ALI. Compared to wild type animals, in CypD-deficient mice, 382 
the level of TNFα and IL-1β produced by resident cells was decreased, indicating that the lack 383 
of CypD could severely interfere with cytokine generation, possibly due to reduced 384 
mitochondrial ROS production. This strong correlation between mitochondrial ROS and 385 
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proinflammatory cytokine production was also reported by Bulua and his coworkers, pointing 386 
to the fact that the blockade of mitochondrial ROS generation efficiently reduces 387 
inflammatory cytokine production after treatment in cells from patients with TNF receptor-388 
associated periodic syndrome and from healthy individuals [29]. 389 
As a counterbalance, IL-10 is a key anti-inflammatory cytokine in the down-regulation of 390 
inflammatory response. One of its key functions is regulation of the pathogen-mediated 391 
activation of macrophages and dendritic cells, consequentially inhibiting the expression of 392 
chemokines, inflammatory enzymes, and potent proinflammatory cytokines. Elevated levels 393 
of IL-10 after LPS exposure did not differ in the two LPS-treated groups, indicating that the 394 
ameliorated inflammatory processes in CypD-deficient animals are not a consequence of anti-395 
inflammatory mechanisms but of attenuated ROS production. 396 
ROS are important chemical mediators that regulate signal transduction pathways, including 397 
members of the MAP kinases. In line with previous studies, [25, 26] we found the increased 398 
phosphorylation of MAPKs in the lungs after LPS treatment. Phosphorylation of redox-399 
sensitive p38 and ERK was markedly decreased in CypD-deficient mice; however, JNK 400 
activation was unaltered in our experiments. Although ROS could activate all three MAPKs, 401 
this regulation is conducted by different upstream regulators independently of each other. It 402 
was previously reported that H2O2 stimulates JNK but not p38 and ERK via a pathway that is 403 
dependent on Src; however, the exact mechanisms for ROS-mediated p38 and ERK activation 404 
remain unknown [30]. Based on our results the depletion of CypD exerts its effect on ROS-405 
induced MAPK activation in p38- and ERK-dependent and JNK-independent ways. Besides 406 
the regulation of upstream mediators of MAPKs, direct control mechanisms could act also 407 
through MKP-1 activity. MKP-1 is a central redox sensitive regulator of ERK and p38 during 408 
endotoxemia, ameliorating monocyte activation and consequential lung injury [31, 11]. Up-409 
regulation of MKP-1 in CypD knock-out mice upon LPS exposure represents a strong 410 
protective pathway due to the attenuated activation of ERK and p38. Previous studies have 411 
shown that p38 is regulated by Akt as well, positively influencing NF-κB activation [32]. 412 
Indeed, the phosphorylation pattern of p38 followed that of Akt in our experiments. Since Akt 413 
could be activated by ROS [33] and IL-1β [32], a lack of CypD could down-regulate the Akt-414 
p38-NF-κB pathway through these inflammatory mediators. In accordance with these 415 
findings, NF-κB and IκB phosphorylation increased dramatically after LPS treatment in the 416 
lungs of wild type but not CypD-deficient animals. Moreover, we proved the functional 417 
inhibition of NF-κB activity in the absence of CypD, analyzing NF-κB-related genes at the 418 
23 
 
mRNA and protein levels. In CypD-deficient mice, the expression of important participants of 419 
TLR4 signaling (CD14, iNOS) and mediators of ALI, like chemokines and cytokines (Cxcl2, 420 
IFNγ, TNFα, IL-1α), showed a significant decrease compared to wild type animals. Our gene 421 
expression data suggest that the downregulation of NF-κB and the related genes by the lack of 422 
CypD may be essential to prevent or treat inflammatory diseases. 423 
In summary, we demonstrate that the loss of essential mPT modulatory protein CypD can 424 
intensely ameliorate endotoxemia-induced lung injury in mice through down-regulation of the 425 
NF-κB pathway, inflammatory mediators and reducing the production of ROS. Our data 426 
highlight a previously unknown regulatory function of mitochondria due to the mediation of 427 
mPT during inflammatory responses. This finding offers a valuable therapeutic target in 428 
conditions of acute inflammation including ALI. 429 
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